Pear Therapeutics

Pioneers in Prescription Digital Therapeutics

There's no other place like Pear

We operate at the intersection of biology and software technology, where researchers and clinicians work side-by-side with software engineers and developers to create the next generation of therapeutics.

Every day, we push the boundaries of technology to transform medicine. Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics, called prescription digital therapeutics (PDTs), to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA.